Generate Biomedicines, Inc. (GENB) stock
GENBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$9.84−0.65 (-6.20%)
Close on Nov 17, 2026Market cap $1.26BP/E –Yield –
Generate Biomedicines operating margin
Operating margin is operating income as a percentage of revenue.
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -2168.4% | −1574.6 |
| Q2 FY2026 | Jun 30, 2026 | -1134.2% | −588.1 |
| Q1 FY2026 | Mar 31, 2026 | -887.5% | – |
| Q3 FY2025 | Sep 30, 2025 | -652.0% | – |
| Q2 FY2025 | Jun 30, 2025 | -593.8% | – |
| Q1 FY2025 | Mar 31, 2025 | -546.1% | – |
See a number that looks wrong?